Application of the Multiattribute Decision-Making Model to Five Proposed Strategies by Hoffman-LaRoche

Edwards (1994) is credited with developing the model called SMARTS (Simple Multiattribute Rating Technique Swing Weights) in the 1980s as a system to assist business people to better prioritize their criteria and more accurately evaluate options. 1 The model devised by Edwards (1994) calls for the fractalization of a problem into component parts, making use of the fact that no decision happens in a vacuum, but has impact on other decisions. Rowe and colleagues (1994) expanded this theory into a Multiattribute Decision-Making Model (MDMM), which enabled a company's decision-makers to break down a complex decision into smaller components, making each one easier to analyze. 2

A decision for a company to launch an R & D program, for instance, has impact on a number of other operations of that company. Human Resources would have to hire the researchers, Accounting would have to modify or expand payroll, Operations personnel would have to allot or create space, buy equipment, and so on. In addition, the decision has impact on a wide number of stakeholders ranging from the shareholders in the company to the competition. It is the purpose of this analysis to apply the MDMM to five proposed strategies being considered by Roche holdings, the parent company of Hoffman-La Roche. Each of the five strategies will be considered and analyzed within the framework of se

. . .
Control factors of Strategy 2 Genoslim extends the company's current control system for product development, therefore no great control issues are inherent that would impact on strategic decision-making. All developments of the Genoslim product will be directed and controlled by the United States division of Hoffman-La Roche. Genoslim is a very good fit for Roche because it will be part of a large worldwide market that is anxious to lose weight. Weighted Factor: 32 Adaptability factors of Strategy 2 Because of potential conflicts with other products in Hoffman-LaRoche's extensive cross-divisional product lines, there should be internal planning to make sure that efforts are not duplicated. In addition, because of the number of competitive products for weight loss enhancers across the price spectrum, are typically low-margin, and should therefore research should be budgeted accordingly, with a series of withdrawal benchmarks built in. Weighted Factor: 28 Work Load factors of Strategy 2 Predicted Managerial Increase 42 Predicted Employee Increase 200 Percentage of internal promotion 30 Percentage of support integration 42 Weighted Factor: 32 Organization factors of Strategy 2 The introduction of Genosli
. . .

Some common words found in the essay are:
Weighted Factor, Market Potential, Strategy Roche's, Europe Roche's, Hoffman-La Roche, Employee Increase, AIDS Profitability, Testing Profitability, Human Resources, weighted factor, factors strategy, SPACE ETOP, strategy 4, strategy #, market potential, factors strategy 5, strategy 3, strategy 1, strategy 2, market share, strategy 5, factors strategy 3, factors strategy 4, factors strategy 2, factors strategy 1,
Approximate Word count = 3268
Approximate Pages = 13 (250 words per page)